SEC Form 4 research
| Issuer | INOTEK PHARMACEUTICALS CORP |
|---|---|
| Tickers | ITEK, RCKT |
| Reporting owners | 65 |
| Officers and directors | 18 |
| Last public filing | 2026-09-16 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-15 | 2026-09-11 | Wilson Martin | S | 75,364 | $3.4 | Not reported |
| 2026-08-20 | 2026-08-18 | Wilson Martin | S | 631 | $3.38 | Not reported |
| 2026-08-20 | 2026-08-18 | Shah Gaurav | S | 2,293 | $3.38 | Not reported |
| 2026-08-17 | 2026-08-13 | Shah Gaurav | S | 2,837 | $3.38 | Not reported |
| 2026-08-17 | 2026-08-13 | Wilson Martin | S | 3,493 | $3.38 | Not reported |
| 2026-08-13 | 2026-08-11 | Stevens Christopher James | S | 36,658 | $3.5 | Not reported |
| 2026-08-13 | 2026-08-11 | Chaudhuri Sarbani | S | 4,701 | $3.5 | Not reported |
| 2026-08-05 | 2026-08-03 | Stevens Christopher James | A | 73,313 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Stevens Christopher James | A | 101,428 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.